Exploratory, Cross-sectional Study to Compare the Virologic Efficacy in Cerebrospinal Fluid (CSF) and Neurocognitive State in Patients Infected by HIV-1 Long-term Treatment (greater than 3 Years) With Lopinavir / Ritonavir Monotherapy.

Trial Profile

Exploratory, Cross-sectional Study to Compare the Virologic Efficacy in Cerebrospinal Fluid (CSF) and Neurocognitive State in Patients Infected by HIV-1 Long-term Treatment (greater than 3 Years) With Lopinavir / Ritonavir Monotherapy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Oct 2013

At a glance

  • Drugs Lopinavir/ritonavir (Primary) ; Emtricitabine/tenofovir disoproxil fumarate
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Feb 2012 Status changed from recruiting to completed.
    • 18 Nov 2010 Actual initiation date changed from Sept 2009 to Aug 2009 as reported by ClinicalTrials.gov.
    • 18 Nov 2010 Planned End Date changed from 1 Sep 2011 to 1 Feb 2011 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top